InvestorPlace - Stock Market News, Stock Advice & Trading Tips
HilleVax stock is down on Monday after HLVX investors learned of a failed Phase 2b clinical trial of its norovirus vaccine for infants.
The post Why Is HilleVax (HLVX) Stock Down 87% Today? appeared first on InvestorPlace.
More From InvestorPlace